Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Bar-Natan

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
The Israel Medical Association Journal : IMAJ|April 8, 2006
Epstein-Barr virus-associated post-transplant lymphoproliferative disorderMichal Bar-Natan, Arnon Nagler
Haematologica|January 2, 2019
New insights into the causes of thrombotic events in patients with myeloproliferative neoplasms raise the possibility of novel therapeutic approachesMichal Bar-Natan, Ronald Hoffman
Expert Review of Hematology|October 5, 2020
Developing strategies to reduce the duration of therapy for patients with myeloproliferative neoplasmsMichal Bar-Natan, Ronald Hoffman
Neurosurgery Clinics of North America|September 19, 2018
Management of Intraoperative CoagulopathyMichal Bar-Natan, Kenneth B Hymes
Annals of Hematology|November 20, 2012
Early death in patients diagnosed with non-Hodgkin's lymphomaOsnat Bairey, Michal Bar-Natan, Ofer Shpilberg
Journal of Hematology & Oncology|October 3, 2020
Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemiaGuido Lancman, John Mascarenhas, Michal Bar-Natan
Blood Reviews|November 4, 2019
JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemiaSangeetha Venugopal, Michal Bar-Natan, John O Mascarenhas
Seminars in Arthritis and Rheumatism|January 16, 2003
Sternoclavicular infectious arthritis in previously healthy adultsMichal Bar-Natan, Moshe Salai, Yechezkel Sidi, et al.
European Journal of Dermatology : EJD|September 21, 2005
Confirmation of the association between male pattern baldness and the androgen receptor geneEtgar Levy-Nissenbaum, Michal Bar-Natan, Moshe Frydman, et al.
Blood Reviews|March 9, 2023
'Secondary' acute lymphoblastic/lymphocytic leukemia - done playing second fiddle?Yosef Joseph Rene Amel Riazat-Kesh, John Mascarenhas, Michal Bar-Natan
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
The Israel Medical Association Journal : IMAJ|April 8, 2006
Epstein-Barr virus-associated post-transplant lymphoproliferative disorderMichal Bar-Natan, Arnon Nagler
Haematologica|January 2, 2019
New insights into the causes of thrombotic events in patients with myeloproliferative neoplasms raise the possibility of novel therapeutic approachesMichal Bar-Natan, Ronald Hoffman
Expert Review of Hematology|October 5, 2020
Developing strategies to reduce the duration of therapy for patients with myeloproliferative neoplasmsMichal Bar-Natan, Ronald Hoffman
Neurosurgery Clinics of North America|September 19, 2018
Management of Intraoperative CoagulopathyMichal Bar-Natan, Kenneth B Hymes
Annals of Hematology|November 20, 2012
Early death in patients diagnosed with non-Hodgkin's lymphomaOsnat Bairey, Michal Bar-Natan, Ofer Shpilberg
Journal of Hematology & Oncology|October 3, 2020
Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemiaGuido Lancman, John Mascarenhas, Michal Bar-Natan
Blood Reviews|November 4, 2019
JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemiaSangeetha Venugopal, Michal Bar-Natan, John O Mascarenhas
Seminars in Arthritis and Rheumatism|January 16, 2003
Sternoclavicular infectious arthritis in previously healthy adultsMichal Bar-Natan, Moshe Salai, Yechezkel Sidi, et al.
European Journal of Dermatology : EJD|September 21, 2005
Confirmation of the association between male pattern baldness and the androgen receptor geneEtgar Levy-Nissenbaum, Michal Bar-Natan, Moshe Frydman, et al.
Blood Reviews|March 9, 2023
'Secondary' acute lymphoblastic/lymphocytic leukemia - done playing second fiddle?Yosef Joseph Rene Amel Riazat-Kesh, John Mascarenhas, Michal Bar-Natan
Pageof 4